Supplementation with vitamin B12/folic acid may restore the autophagic capacity of Stx17 and reduce inflammation and fibrosis in patients with non-alcoholic steatohepatitis (NASH) and may represent a new option as first-line treatment for NASH 31. Here, STX17 is linked to metabolic dysfunction-associated steatohepatitis.